PUBLISHER: IMARC | PRODUCT CODE: 1467933
PUBLISHER: IMARC | PRODUCT CODE: 1467933
The global hydrogel dressing market size reached US$ 453.9 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 697.9 Million by 2032, exhibiting a growth rate (CAGR) of 4.75% during 2024-2032.
Hydrogel dressings rehydrate necrotic and sloughy tissue to effect debridement while providing moisture to wounds. They comprise water suspended in a gel made up of insoluble hydrophilic polymers, which swell up on contact with water. They are manufactured from polymers of synthetic molecules, such as polymethacrylate and polyvinylpyrrolidone. They control the exchange of fluid at the wound-bandage interface, promote granulation, and encourage complete healing. They assist in alleviating pain while preventing dead space from becoming infected. In addition, they boost wound re-epithelialization as hydrogel dressings partially mimic skin structure and enhance the growth of skin components. As a result, they find extensive applications in hospitals, specialty clinics, and home healthcare centers across the globe.
At present, the growing prevalence of chronic wounds, such as venous, pressure, and ischemic ulcers, represents one of the key factors driving the market. Besides this, governments of several countries are undertaking initiatives to increase awareness about the diagnosis and treatment of diabetic foot ulcers, which is contributing to the growth of the market. Moreover, key market players are extensively investing in research and development (R&D) activities to introduce cost-effective products for improving the treatment of chronic wounds. They are also focusing on marketing strategies to boost their sales. In addition, the growing utilization of hydrogel dressings to keep wounds clean by eliminating diseased or necrotic tissues via autolysis is offering a positive market outlook. Apart from this, the increasing demand for advanced wound care products to prevent surgical site infections is offering lucrative growth opportunities to industry investors. Additionally, there is a rise in the incidence of blood clotting in trauma cases around the world. This, along with the burgeoning healthcare industry, is bolstering the growth of the market.
IMARC Group provides an analysis of the key trends in each sub-segment of the global hydrogel dressing market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on product, material, application and end user.
Amorphous Hydrogel
Impregnated Hydrogel
Sheet Hydrogel
Natural
Synthetic
Semi-synthetic
Diabetic Foot Ulcer
Pressure Ulcer
Venous Leg Ulcer
Burn Wounds
Others
Hospital
Physician's Office
Others
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The competitive landscape of the industry has also been examined along with the profiles of the key players being 3M Company, Axelgaard Manufacturing Co Ltd, B Braun Melsungen AG (B. Braun Holding GmbH & Co. KG), Convatec Group plc, Hollister Incorporated, Integra LifeSciences, Lohmann & Rauscher GmbH & Co. KG (Lohmann & Rauscher International GmbH & Co. KG), McKesson Corporation, Medline Industries LP, Procyon Corporation and Smith & Nephew plc.